Beijing on Sunday issued an "orange" pollution alert and has maintained the alert today. Heavy smog has covered the capital and is likely to affect all activities in the region. The authorities are closing highways, construction activities and urging residents to minimize outdoor activities and to stay indoors, Reuters reported.
Beijing's Environmental Protection Bureau introduced four types of pollution alerts - blue, yellow, orange and red in March, red being the most hazardous level. RT says that all factories are to be shut down during orange alerts, along with complete ban of heavy vehicles, such as construction trucks, during orange and red alerts.
South China Morning Post reported that according to Aqicn.org, a Beijing real-time air-quality monitoring website, on Saturday peak readings of PM 2.5 (airborne particles smaller than 2.5 microns in diameter that cause smog) had reached 464 micrograms per cubic metre in Beijing's Yongdingmen area at 1pm.
The particle level dropped below 200 on Sunday but was still significantly higher than the “safe” levels. According to the World Health Organization (WHO), only 25 micrograms is considered to be a safe level, RT pointed out.
The Ministry of Environmental Protection said that "unfavorable" weather has caused the suffocating pollution. The ministry said the number of cities affected by heavy pollution now stands at 23, however a cold front starting on Wednesday would see improvement in the situation.
Reuters reported that following a number of smog outbreaks in Beijing and surrounding areas, China launched a "war on pollution" in 2014. The country has vowed to reduce coal consumption and close down polluting industrial capacity. However, environmental officials admit that China is unlikely to “meet state air quality standards until at least 2030.”


Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 



